Prostate Cancer Doctors Worldwide

Dr. Jan Dolezel is a prominent onco-urologist at the Robotic Surgery Center in St. Zdislava Hospital. He is a primary specialist for Da Vinci robotic surgery in the Czech Republic. Dr. Dolezel specializes in robotic prostatectomy, nephrectomy, and kidney-sparing procedures. He received specialized robotic and laparoscopic training at the University of Strasbourg in France.

• Published over 100 scientific papers in medical journals.
• Maintains active membership in the European Society of Urology.
• Treats complex conditions like adenocarcinoma and benign prostatic hyperplasia.
• Practices at the largest robotic surgery center in the Czech Republic.

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in complex sarcoma cases.

• Over 41 years of experience in oncology
• Fellowship-trained at Institut Gustave Roussy in Paris
• Member of ESMO Sarcoma Faculty and ASCO
• Published extensively on orthopedic oncology outcomes

Dr. Altay Aliyev specializes in advanced prostate cancer treatments, combining hormonal therapy with targeted and immunotherapy approaches. His research at Cleveland Clinic and Istanbul University brings cutting-edge knowledge to patient care.

• Trained in medical oncology at Istanbul University
• Research associate at Cleveland Clinic's Endocrinology Department
• Published multiple studies on cancer treatment outcomes
• Specializes in cytotoxic chemotherapy and hormone therapy
• Focuses on early diagnosis and palliative cancer care

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Carme Ares heads the Radiation Oncology Department at Quirónsalud Proton Therapy Center in Madrid. She is a specialist in proton therapy and radiation oncology. Dr. Ares completed a clinical fellowship at Massachusetts General Hospital, a Harvard Medical School affiliate. She has practiced at top clinics in Switzerland and the Netherlands.

• Authored over 30 scientific articles in peer-reviewed medical journals.
• Treats patients at Spain's first proton therapy center.
• Uses the Proteus One system for precise tumor scanning and dosing.
• Works at a center accredited by Joint Commission International and ESMO.

Dr. Stephanie Lilianne E. Bolle is a radiation oncologist and Head of Radiation Oncology at the Quirónsalud Proton Therapy Center in Madrid. She has led the department since July 2024. The center is Spain’s first proton therapy facility.

MD, University of Liège (1998). Board certified in radiation oncology (2003). She is an active member of the European Society of Paediatric Oncology and works with its Brain Tumor Group and Radiation Oncology Working Group.

She has published more than 120 scientific articles on pediatric brain tumors, proton therapy, pediatric radiation doses, and complex radiotherapy. She takes part in international projects and clinical trials, including BIOMEDE 2 and HARMONIC. Her expertise includes proton therapy, pediatric oncology, CNS and skull base tumors in adults and children, sarcomas, and complex radiotherapy planning.

Dr. Enrique Grande is a renowned medical oncologist at Hospital Ruber Internacional in Madrid. He has authored over 300 peer-reviewed scientific publications. Dr. Grande focuses on genitourinary and rare endocrine tumors. He serves as a pioneer in precision oncology and molecular profiling.

• Directs the Medical Oncology Department at QuirónSalud.
• Treats complex cases of bladder, kidney, and prostate cancers.
• Contributes to international guidelines for ESMO and ASCO.
• Leads global clinical trials to set new cancer care standards.

Dr. David Kuczer is a radiation oncologist at Amethyst Radiotherapy in Vienna. He specializes in precise cancer treatment for tumors of the prostate, breast, and brain. Dr. Kuczer presents every patient case to an interdisciplinary tumor board. This ensures each person receives a validated treatment plan from a team of experts.

• Uses the Elekta Versa HD linear accelerator for precise tumor targeting.
• Treats complex conditions including glioblastoma, lung cancer, and meningioma.
• Coordinates care within a clinic ranked among Newsweek's World's Best Hospitals 2026.
• Provides IMRT, VMAT, and stereotactic radiosurgery for high-accuracy radiation.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Professor of Medical Oncology with over 27 years of experience – Prof. Sağlam leads the department at Gayrettepe Florence Nightingale Hospital.

• Specializes in gastrointestinal oncology with extensive training at Istanbul University
• Member of prestigious organizations including ESMO and ASCO
• Fellowship-trained at Istanbul University's Medical Faculty
• Previously worked at American Cancer Center in Istanbul

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Antonio Alcaraz specializes in prostate cancer treatment, performing over 500 urogenital surgeries with minimally invasive techniques and the Da Vinci robotic system.

• 38 years of experience in urology and uro-oncology
• Heads the Department of Urology at Teknon Medical Center
• Member of American Urological Confederation and European Urological Society
• Expert in robotic-assisted prostate cancer surgeries

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Professor Sefik Igdem specializes in prostate cancer radiation oncology, using advanced technologies like Truebeam Stx and Halcyons at Gayrettepe Florence Nightingale Hospital.

• 30 years of experience in radiation oncology
• Expert in conformal treatments for prostate cancer
• Professor at T.R Demiroğlu Bilim University
• Specializes in head and neck cancers as well

Dr. Shira Felder leads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior radiation oncologist specializing in gynecologic and urologic cancers. She trained at the Princess Margaret Cancer Centre in Toronto. Dr. Felder focuses on delivering targeted radiation while preserving her patients' quality of life.

• Uses precision techniques including VMAT, IMRT, SBRT, and brachytherapy.
• Treats cervical, uterine, ovarian, and prostate cancers.
• Maintains membership in the European Society for Radiotherapy & Oncology.
• Works at Sheba Medical Center, ranked 7th globally by Newsweek.
• Conducts research on brachytherapy safety and cervical cancer survival.

Prof. Montorsi has performed over 8,000 urology surgeries, specializing in minimally invasive and robotic techniques for prostate cancer at San Raffaele.

• Director of the Urological Research Institute – a leading center in Italy
• Recipient of the Hugh Hampton Young Award – first non-American to receive it
• Published over 1,000 papers on urology and oncology
• Honorary fellowship from the Royal College of Surgeons of England

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Head of Radiotherapy at San Raffaele Hospital – Prof. Di Muzio specializes in high-precision hypofraction methods for prostate cancer, with over 33 years of experience.

• Italian Coordinator of the Brachytherapy Italian Group since 1999
• Author of 200 studies in radiation oncology research
• Member of the European Society for Radiotherapy and Oncology
• Professor at Vita University and lecturer at multiple medical schools